Unknown PHASE1 INTERVENTIONAL 2-arm NCT03772418

Topical Preparation of Pomegranate and Ginkgo Biloba for Anti-aging Activities

Formulation and Evaluation of Topical Preparation Containing Pomegranate and Ginkgo Biloba for Anti-aging Activities

Sponsor: Ahmed A. H. Abdellatif

Conditions Skin and Subcutaneous Tissue Disorders

Interventions Cream Base Pomegrante and Ginkgo biloba group

Updated 5 times since 2019 Last updated: Dec 8, 2018 Started: May 18, 2018 Primary completion: Jan 1, 2020 Completion: Feb 28, 2020

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT03772418, this PHASE1 trial focuses on Skin and Subcutaneous Tissue Disorders and remains ongoing. Sponsored by Ahmed A. H. Abdellatif, it has been updated 5 times since 2018, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

5 versions recorded

Sep 2025 — Present [monthly]

Unknown PHASE1
Sep 2024 — Sep 2025 [monthly]

Unknown PHASE1
Jul 2024 — Sep 2024 [monthly]

Unknown PHASE1

Status: Unknown Status → Unknown
Jan 2021 — Jul 2024 [monthly]

Unknown Status PHASE1

Status: Recruiting → Unknown Status
Jan 2019 — Jan 2021 [monthly]

Recruiting PHASE1

First recorded

May 2018

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Ahmed A. H. Abdellatif

Data source: Al-Azhar University

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Asyut, Egypt
• Buraidah, Saudi Arabia